Skip to Content

Tag: CPAP Device


Woody O'Neal

Providers

Providers face ‘new era’ in online shopping 

December 13, 2024Theresa Flaherty, Managing Editor

YARMOUTH, Maine – ResMed’s decision to add the AirSense 11 to its e-shop is another sign of a shifting market – one that providers have mixed feelings about.  ResMed was already selling its AirSense 10 and AirMini, as well as numerous masks and accessories, on the e-shop for cash purchase, and added the AirSense 11 in October. Inogen, a manufacturer of portable oxygen concentrators, has offered a direct-to-consumer option for years.  “We're seeing that...

AirSense 11, CPAP Device, Online shopping, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed adds AirSense 11 to e-shop 

November 22, 2024Liz Beaulieu, Editor

SAN DIEGO – ResMed has added the AirSense 11 to its e-shop for cash purchase in a move that has upset providers who say they are still on allocation for this CPAP device.  When contacted by HME News, a company spokesperson confirmed that the AirSense 11 joined the AirSense 10 and AirMini, as well as numerous masks and accessories, on the company’s e-shop on Oct. 28.  “The expansion of our online shop reflects our broader commitment to developing a holistic channel...

AirSense 11, allocation, CPAP Device, e-shop, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed announces strategy, outlook 

October 1, 2024HME News Staff

SAN DIEGO – ResMed unveiled its 2030 strategy to drive growth, profitability and shareholder returns, including investing 7% in R&D, at an Investor Day in New York City.  The company also announced its five-year revenue and earnings growth outlook, reflecting its plans to accelerate product and technology innovation, operational excellence, commercial execution and financial strength.  “By building on our leadership in connected digital health, our 2030 Strategy will further...

CPAP Device, CPAP Mask, Outlook, ResMed, Strategy


Read Full Articlered right arrow icon

Providers

Providers sue Philips for cutting them off 

July 16, 2024HME News Staff

PHILADELPHIA – Dynamic Healthcare Services and Hometown Oxygen Pittsburgh on July 15 filed a lawsuit against Philips Respironics, DeLage Landen Financial Services and Philips Medical Capital for cutting off access to financing and leasing programs that the providers say are necessary for them to compete.  According to the lawsuit, filed in the U.S. District Court for the Eastern District of Pennsylvania:  Prior to the Philips recall, DHS purchased thousands of respiratory...

CPAP Device, Dynamic Healthcare Services, Financing, Hometown Oxygen Pittsburgh, Leasing, Philips Medical Capital, Philips Recall


Read Full Articlered right arrow icon

Also Noted

Researchers develop new CPAP design 

July 9, 2024HME News Staff

CINCINNATI – Researchers at the University of Cincinnati are developing a PAP machine that uses vortex airflow technology, a mechanism commonly used in aerospace engineering applications, to eliminate the need for a tight seal. As a result, the VortexPAP is able to use a mask that is designed to barely touch the patient’s face, increasing comfort, researchers say. “Despite the clinical efficacy for CPAP in controlling OSA, patient compliance with the therapy remains a major cause...

CPAP Device, CPAP Mask, VortexPAP


Read Full Articlered right arrow icon

Vendors

Philips wants SoClean to pay part of settlement 

May 16, 2024HME News Staff

PITTSBURGH – Philips has sued SoClean in a bid to get the company, whose ozone cleaners it says “attacks” the foam in its CPAP devices, to pay part of its recently announced $1.1 billion settlement.  Philips announced the settlement in April to resolve the personal injury litigation and the medical monitoring class action related to a recall of certain sleep and respiratory devices in the U.S.    “(SoClean’s) negligent and intentionally misleading...

CPAP Device, Lawsuit, ozone cleaning, Philips, SoClean


Read Full Articlered right arrow icon

Roy Jakobs

Vendors

Philips has ‘finality’ 

May 1, 2024Liz Beaulieu, Editor

AMSTERDAM – Philips has a renewed focus, says CEO Roy Jakobs, now that the company has resolved additional settlements and finalized a consent decree related to a large recall of certain devices in its Sleep and Respiratory Care business unit.  The company recently announced that it has agreed to pay $1.1 billion from its cash flow generation to resolve personal injury litigation and medical monitoring class action in the U.S. This follows an economic loss settlement finalized last...

Consent Decree, CPAP Device, Philips Recall, Settlement


Read Full Articlered right arrow icon

News

Survey finds improving supply for CPAP devices 

March 18, 2024HME News Staff

NEW YORK – Respondents saw a 6% increase in sleep patient volume, on average, in the last 12 months, according to the HME Sleep and Oxygen Survey for the first quarter of 2024 from Needham and Co.  Respondents expect 6.5% growth in the next 12 months.  “We suspect that the increase is due to improving flow generator supply and HMEs engaging both new and backlogged patients that resulted from the Philips Respironics recall,” the report stated.  Other...

CPAP Device, Needham, Patient volume, Sleep Therapy


Read Full Articlered right arrow icon

News

In brief: React Health and Rotech CEOs, Philips medical device reports 

February 7, 2024HME News Staff

SARASOTA, Fla. – React Health has appointed Bill Shoop, most recently vice president and general manager of ResMed North America, as its CEO.  “I am extremely excited about the opportunity to join this experienced and talented team,” he said. “I believe React Health is very well positioned to help the industry and continue to advance our mission of delivering innovative solutions that positively impact patients’ lives and the people that care for them.”  Shoop,...

CPAP Device, Philips, React Health, Rotech Healthcare


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed starts tracking patients on both weight loss drugs, CPAP therapy

January 5, 2024Liz Beaulieu, Editor

YARMOUTH, Maine – ResMed CEO Mick Farrell believes that, based on the company’s early research, weight loss drugs will be a “net positive” for patient flow for sleep apnea.  “I mean, I think there's $1 trillion worth of market cap now from these (pharmaceutical) companies and they will turn that into marketing to bring people in for the miracle drug,” he said during a recent conference call to discuss ResMed’s latest financial results. “And...

CPAP, CPAP Device, Mick Farrell, ResMed, weight loss drugs


Read Full Articlered right arrow icon